Analyst Activity – Royal Bank of Canada Initiates Coverage On Aurinia Pharmaceuticals (NASDAQ:AUPH) With a Outperform

Analyst Ratings For Aurinia Pharmaceuticals (NASDAQ:AUPH)

Story continues below

Today, Royal Bank of Canada initiated coverage on Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Outperform with a price target of $9.00.

Some recent analyst ratings include

  • 2/8/2018-Royal Bank of Canada initiated coverage with a Outperform rating.
  • 11/15/2017-HC Wainwright Reiterated Rating of Buy.
  • 10/23/2017-Cantor Fitzgerald Reiterated Rating of Buy.
  • 10/6/2017-Seaport Global Securities Reiterated Rating of Buy.
  • 4/11/2017-FBR & Co Reiterated Rating of Outperform.


    Recent Trading Activity for Aurinia Pharmaceuticals (NASDAQ:AUPH)
    Shares of Aurinia Pharmaceuticals closed the previous trading session at 5.40 up +0.23 4.45% with 5.269999980926514 shares trading hands.

    An ad to help with our costs